A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid ...

Gruijl TD, van der Vliet HJ. Highly specific and potently activating. Vg9Vd2-T cell specific nanobodies for diagnostic and therapeutic.







A bispecific nanobody approach to leverage the potent and widely ...
Gruijl TD, van der Vliet HJ. Highly specific and potently activating. Vg9Vd2-T cell specific nanobodies for diagnostic and therapeutic.
La Propriété Industrielle - WIPO
bedingt und Stand der Technik. Ausfälle von elektroni- schen Betriebsgeräten und LED-Modulen, die innerhalb der Nennausfallrate von 0 ...
v. annexes - Gest'eau
o u t r e les ga r a n t i es a pp l i ca bl es â t o u t e s les r o nnes soum i se s à r é t en t i o n , l a. l o i. d u. 10 j u i n 1 9 ...



Autres Cours:

Les nanobodies, nouvelle génération de médicament ... - DUMAS